Compare MLYS & FIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLYS | FIVN |
|---|---|---|
| Founded | 2019 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.4B |
| IPO Year | 2023 | 2014 |
| Metric | MLYS | FIVN |
|---|---|---|
| Price | $25.85 | $34.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 18 |
| Target Price | ★ $48.67 | $26.06 |
| AVG Volume (30 Days) | 1.2M | ★ 2.0M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 37.43 | ★ 364.71 |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $1,149,088,000.00 |
| Revenue This Year | N/A | $11.39 |
| Revenue Next Year | N/A | $10.00 |
| P/E Ratio | ★ N/A | $143.12 |
| Revenue Growth | N/A | ★ 10.28 |
| 52 Week Low | $22.30 | $13.29 |
| 52 Week High | $47.65 | $40.00 |
| Indicator | MLYS | FIVN |
|---|---|---|
| Relative Strength Index (RSI) | 39.48 | 53.48 |
| Support Level | $22.36 | $30.38 |
| Resistance Level | $31.36 | $34.88 |
| Average True Range (ATR) | 1.48 | 2.07 |
| MACD | -0.40 | 0.11 |
| Stochastic Oscillator | 5.09 | 46.77 |
Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Intelligent CX platform combines core telephony functionality, omnichannel engagement, and modules into a cloud-based contact-center-as-a-service platform. Five9's modules include digital self-service, agent assist technology, workflow automation, and optimization solutions, as well as artificial intelligence-driven automation solutions that optimize customer service efficiency and manage interaction quality and agent performance.